Test 2 Flashcards

(80 cards)

1
Q

describe TOC

A

movement of pt between a healthcare system and providers. ensure coordination among healthcare professionals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pre-discharge

A

med rec, pt edu, discharge planning, scheduling follow-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

post-discharge

A

follow-up phone call,

communication with ambulatory provider, home visits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bridging

A

transition coach that acts as a patient advocate, patient-centered discharge instructions to increase patient buy-in, clinician continuity with inpatient/outpatient providers, transition coach may attend follow up visits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

groups at high risk for adverse drug events within care transitions

A

older adults, limited health literacy, terminal patients, children with special needs, patients taking more than 5 meds daily, cognitive impairment, complex medical/behavioral health conditions, lower income, new admits to LTCF, homeless

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pharmacists role in TOC

A

med reconciliation: comparing med history and what physician has ordered at admin, transfer, discharged to avoid omissions, errors, duplicates, and ADE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pharmacists role at admin

A

identify outpatient meds (history), assess adherence and health literacy, reconcile with current medical state

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pharmacists role at inpatient transfer

A

ensure adequate hand-off to ensure continuity between

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

pharmacists role at discharge review

A

med list correct and optimized based on inpatient changes, counsel, assess access to medications, promote adherence, follow-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

community pharmacist activities after discharge

A

perform home visits, review automated refill programs, help with interpretation of discharge paperwork, assist with third-party formulary review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

create a plan for improving medication management during TOC

A
  • start patient education earlier (days before discharge), use established educational techniques, follow-up with patient after discharge
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Comparative Effectiveness Research (CER)

A

CER is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition or improve the delivery of care. Purpose is to inform decisions that will improve healthcare at both the individual and population levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

1972 CER

A

establishment of the Office of Technology Assessment (OTA), an advisory committee to Congress tasked with evaluating the effectiveness of healthcare services

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

1975 CER

A

establishment of the National Center for Healthcare Technology (NCHT) with the purpose of endorsing research on health technologies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

1989 CER

A

establishment of what came to be known as the Agency for Healthcare Research and Quality (AHRQ) to facilitate the development of timely evidence and update clinical practice guidelines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2003 CER

A

Medicare Prescription Drug, Improvement, and Modernization Act (MMA) mandates that the AHRQ conduct research into effective healthcare programs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

2009 CER

A

American Recovery and Reinvestment Act provided funding for CER, mandated the establishment of the Federal Coordinating Council for CER, and required the IOM to report back to Congress within a few months of passage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

2010 CER

A

establishment of the Patient-Centered Outcomes Research Institute (PCORI), a non-profit, independent organization to fund CER initiatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

American Recovery and Reinvestment Act legislated efforts for CER

A

increased funding for CER by 1.1 billion
established federal coordinating council for CER
purpose: help agencies of the federal government in coordinating comparative effectiveness and related health services research
agencies: AHRQ, NIH, CDC, CMS, FDA, VA
coordination functions: research infrastructure, methods and workforce development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

efficacy- CER

A

health care intervention is beneficial when administered under optimal circumstances. efficacy is whether or not something works under carefully controlled conditions.
Efficacy studies have strict inclusion/exclusion criteria, involve highly standardized treatments, have explicit procedures for ensuring compliances, and focus on direct outcomes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

RCT

A

The gold standard of generation of efficacy data is through randomized clinical trials (RCTs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Effectiveness - CER

A

health care intervention does more good than harm when provided to a wide assortment of real-world patients with different baseline health risks by physicians or other care providers practicing in diverse clinical settings. effectiveness is how well something works under actual conditions.
Effectiveness studies have looser inclusion/exclusion criteria, involve treatments carried out by typical clinical personnel, have little or no provision for ensuring compliance, and focus on less direct outcomes (e.g., quality of life).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Generation of effectiveness data is done through

A

effectiveness trials, pragmatic trials, and observational studies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

tenets distinguish CER from clinical research in general

A
  • informs a specific clinical decision from the individual patient perspective or health policy decision from the population perspective
  • compares two alternative interventions that provide benefit
  • describes results at the population and subgroup levels
  • measures outcomes - both benefits and harms - that are important to patients and decision makers
  • employs methods and data sources appropriate for the decision of interest
  • conducted in settings that are similar to those in which the intervention will be used in practice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Range of CER methods
1. Experimental studies, RCT, assigned treatments, practices, policies 2. Prospective observational studies - registries, observe patterns and of care and outcomes - do not assign patients to specific study groups 3. Retrospective studies 4. Decision models with or without cost info 5. Systematic reviews of existing research including meta-analyses
26
Stakeholder
Individuals, orgs or communities that have a direct interest in the process and outcomes of a project, research, or policy endeavor
27
Stakeholder engagement
Iterative process of actively soliciting the knowledge, experience, judgement and values of individuals selected to represent a broad range of direct interests in a particular issue, for the dual purpose of: - creating a shared understanding, and relevant, transparent, and effective decisions - making relevant, transparent, and effective decisions
28
Stake holder categories in CER
Patients/consumers, clinicians, healthcare providers, payers/purchasers, policy makers/regulators, life sciences industry, researchers, research funders
29
Considerations for CER question
Population, intervention, comparator, outcomes, timing, setting
30
Future implications
Participatory research methods may produce evidence-based interventions
31
Healthcare orgs can advance CER by investing in
1. Personnel dedicated to data collection, monitoring, and interpretation 2. Data infrastructure / analytics 3. Evidence-based quality improvement initiatives 4. Adaptive implementation and dissemination strategies
32
Race
Physical characteristic and/or genetic or biological makeup Social, not scientific construct Developed in notions of racial superiority In 2010 census includes 15 racial categories
33
Ethnicity
Characteristics of people who share a common and distinctive racial, national, religious, linguistic, or cultural heritage Geographic origins, family patterns gender roles, religion, literature/music, employment, language/ symbols, values / cultures
34
What are the 2 ethnic categories in the US census
Hispanic / non-Hispanic
35
Culture
Integrated patterns of human behavior that include the language, thoughts, communications, actions, customs, beliefs, values, and institutions of racial, ethnic, religious, or social groups Culture is learned, passed from generations, complex, subcultures
36
Cultural considerations in healthcare
``` Perceptions of health/illness Why illness occurs Health behaviors How symptoms are described / how concerns are expressed Treatment is pursued and followed ```
37
Why do we have unconscious bias
Storing social knowledge from experience and learning Familiar cues trigger an association with stored social knowledge Automatic application of social knowledge to a current situation
38
Health literacy
The degree to which individuals have the capacity to obtain, process,and understand basic health information needed to make appropriate health decisions
39
Literacy impact areas
Med non-adherence Identification of meds Limited understanding of instruction Increased med errors
40
Health, health care, and health equity impact (limited literacy)
- negatively impacts online access and use - hinders patient - provider communication - reduces opportunity for self-care - negatively impacts health services navigation - impedes understanding of health info
41
Patient protection and affordable care act section number and about
Sec 3507, presentation of prescription drug benefit and risk information, directs the secretary to determine whether the addition of certain standardized information to prescription dug labeling and print advertising would improve health care decision-making by clinicians and patients and consumers; to consider scientific evidence on decision-making and to consult with various stakeholders and experts in health literacy
42
Healthy people
HC/HIT- 1.1-3 - easy to understand instructions, US department of health and human services
43
National action plan to improve health literacy
All-inclusive approach to reach goals - all people have the right to health info that helps them make decisions, services should be delivered in a way that is easy to understand
44
Health literacy online
Various grade levels, guide for designing online resources for all health care consumers
45
Health literacy workgroup
Dedicated to improving literacy in the US and resource for national health care agencies
46
Health literacy workgroup
Workgroup dedicated to improving literacy in the US and a resource for national health care agencies
47
AHRQ patient assessment tools
Patient edu materials assessment tool for printable materials Short assessment of health literacy - Spanish and english Rapid estimate of adult literacy in medicine Short assessment of health literacy for Spanish adults
48
Pharmacists expectations and system demands
Managing medications, remembering and following spoken and written directions, interpretation
49
Adult skills - literacy
Majority of U.S. adults have trouble using print materials to do everyday tasks 0 calculate 15% tip (quantitative) Reading medication how much to give to a child, etc
50
Proficient literacy
Define medical terms from a complex document, calculate share of employee’s health insurance costs
51
Intermediate literacy
Determine healthy weight from BMI chart, interpret prescription and OTC labels
52
Basic literacy
Understand simple patient edu handout
53
Below basic literacy
Circle date on appointment slip, understand simple pamphlet about pre-test instructions
54
High-risk health literacy groups
No English, homeless, prisoners, limited edu, limited English proficiency (LEP), patients, minorities
55
We expect patients to...
Read labels etc Track experiences - side effects, take action Calculate- count dose, time, amount left
56
Patient-level consequences with literacy
Poorer health outcomes, missed refill, emergency care use, difficulty understanding meds
57
Medication errors - what you should say
How do you take this medicine, how many pills in one day
58
Societal consequences with poor health literacy
Non-adherence, inc ED costs among low health literacy patients, undermines efforts to increase patient self-management and engagement in care
59
Pharmacy consequences to poor health literacy
Impact on customer loyalty and satisfaction, decreased profits due to missed refills, liability
60
Pharmacoepidemiology
Study of the use and effects of drugs in populations. Post marketing surveillance - seek to quanitfy drug utilization patterns, conduct safety studies to examine drug safety and ADE
61
Pharmacoepidemiology Rationale
Med costs inc, polypharm, cost-effective care, unethical to conduct some studies using experimental format
62
Users of pharmacoepidemiology research
Gov, pharm industry, practitioners, academics, attorneys, consumers, international users
63
Phases of pharmacoepidemiology through drug development and post marketing
1. Preclinical - IND 2. Phase 1- safety - healthy volunteers 3. Phase 2- efficacy- 100-200 puts with disease 4. Phase 3 - dosing/population studies - >500 puts with disease 5. NDA - post marketing
64
FDA approval process limitations
Based on clinical trials May exclude important age groups of patients - children/women of child-bearing age - sample sizes - short duration
65
Post marketing surveillance
Gathering info about a product after it has been approved for public use - process for measuring drug safety after FDA approval identify potential problems - info gathered via phase 4 clinical trials, post-marketing studies, and adverse event reporting systems - pharmaceutical companies must report to the FDA annually on the progress of their post-marketing studies
66
Pharmacoepidemiology during postmarketing
Evaluate safety signals, describe drug utilization in populations (adherence/off-label use), examine adverse events, develop post-authorization safety studies (PASS)
67
Adverse event reporting systems
FDA has established medwatch/VAERS safety Voluntary system Purpose: identify and evaluate risk with a specific product, develop interventions to modify the risk, and communicate risk
68
Other reporting systems
Spontaneous reporting pharmaceutical companies, case reports
69
Spontaneous event reporting limitations
No control group, hard to estimate frequency / rate at which the drug effect occurs, no adequate info about drug exposure, no causative association, potential bias, voluntary, inc healthcare informatics/databases
70
Potential pharmacoepidemiology research questions
Patterns of use, safety, effectiveness, economic evaluations
71
Examples of outcomes of post market ADE reporting
Product recall, boxed warning, contraindications, new warnings, precautions, ADE, dose adjustments, letters to health care professionals
72
Pharmacists role
Drug experts, identify problems, ADE reporting, interpret PE studies, conduct drug use evaluations; develop guidelines, medication adherence proponents, conduct pharmacoepidemiology cal research
73
CER 1972
establishment of the office of technology assessment (OTA), advisory committee to Congress tasked with evaluating the effectiveness of healthcare services
74
CER 1975
national center for healthcare and technology (NCHT) purpose of endorsing research on health technologies
75
CER 1989
establishment of what is known as the Agency for Healthcare Research and Quality (AHRQ) to facilitate the development of timely evidence and update clinical practice guidelines
76
CER 2009
American Recovery and reinvestment act provided funding for CER , mandated the establishment of the federal coordinating council for CER and required the IOM to report back to congress within months of passage
77
CER 2003
medicare prescription drug, improvement, modernization act (MMA) mandates that the AHRQ must conduct research into effective healthcare programs
78
CER 2010
establishment of the patient-centered outcomes research institute (PCORI), a non-profit, independent organization to fund CER initiatives
79
American Recovery and Reinvestment Act legislated efforts for CER
increased funding for CER by 1.1 billion established the federal coordinating council for CER purpose: assist agencies of the federal gov in coordinating comparative effectiveness and related health services research agencies: AHRQ, NIH, CDC, CMS, FDA, VA coordination functions: research infrastructure, methods and workforce development
80
efficacy with respect to CER
extent to which a health care intervention is beneficial when administered under optimal circumstances. whether or not something works under carefully controlled conditions. - strict inclusion/exclusion criteria, procedure, focus on direct outcomes, gold standard of generation of efficacy data through randomized controlled